RE: Noos-sooN ?18 May 2018 17:28
Extract from Hardman report when the sp was 3p......VAL is undervalued relative to its peers at a similar stage
of development. The reason for this is certainly its need for more capital to
advance its clinical programmes, thereby building value.
Come on Val BOD and raise the capital.....cheapest route, please.....definitely not more 2p's